Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder with a low survival rate. Pulmonary fibrosis is one of the complications of COVID-19 and has a high prevalence in COVID-19 patients. Currently, no effective therapies other than lung transplantation are available to cure IPF and post-COV...
Saved in:
Main Authors: | Lingyue Yan (Author), Yafei Su (Author), Isaac Hsia (Author), Ying Xu (Author), Vui King Vincent-Chong (Author), Wilfrido Mojica (Author), Mukund Seshadri (Author), Ruogang Zhao (Author), Yun Wu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adrenergic-Angiogenic Crosstalk in Head and Neck Cancer: Mechanisms and Therapeutic Implications
by: Vui King Vincent-Chong, et al.
Published: (2021) -
MicroRNA Dysregulation in Cystic Fibrosis
by: Paul J. McKiernan, et al.
Published: (2015) -
Transforming growth factor-beta and microRNA-21, microRNA-29b, microRNA-92, and microRNA-129 in systemic sclerosis patients: a case-control study
by: Mohammed Hassan Mohammed, et al.
Published: (2022) -
MicroRNA-21: An Emerging Player in Bone Diseases
by: Chen Chen, et al.
Published: (2021) -
MicroRNA-21 and microRNA-29a modulate the expression of collagen in dermal fibroblasts of patients with systemic sclerosis
by: Saeideh Jafarinejad-Farsangi, et al.
Published: (2019)